
Product Overview
A global leader in hemodynamic monitoring and left ventricular assist devices
We are the world’s leader in pulmonary artery pressure monitoring and left ventricular assist devices for heart failure.
Heart Failure became a division in 2021 after splitting from Electrophysiology and Cardiac Rhythm Management. Its pulmonary arterial monitoring and LVAD technology came via Abbott’s 2017 acquisition of St. Jude, which had acquired CardioMEMS and Thoratec.
Learn more about the CardioMEMS implant procedure




